Shareholding disclosure

Mauro Severino Ajani

Declared position

Threshold

Fell below threshold

Timeline

Published

10.12.2021

Transaction

02.12.2021

Transfer date

17.12.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TALC900072

Beneficial owner

Mauro Severino Ajani

Declared address

Mauro Severino Ajani, Lugano

Acceptance of exchange offer from Cosmo Pharmaceuticals N.V.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Mauro Severino Ajani

Cassiopea S.p.A.10.12.2021TALC900072

Disclosure summary

Mauro Severino Ajani disclosed a holding in Cassiopea S.p.A. that fell below the publication threshold, published by SIX Exchange Regulation on 10.12.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Mauro Severino Ajani disclosed a holding in Cassiopea S.p.A., published on 10.12.2021.

Publication date10.12.2021

Transaction date02.12.2021

Transfer date17.12.2021

Issuing companyCassiopea S.p.A.

Beneficial ownerMauro Severino Ajani

Declared addressMauro Severino Ajani, Lugano

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTALC900072

Conditions

Acceptance of exchange offer from Cosmo Pharmaceuticals N.V.

Source: SIX Exchange Regulation · Publication date: 10.12.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open